Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia | MicrobiomeTrials← Back to trialsNCT03945448
Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia
RecruitingPHASE2, PHASE3INTERVENTIONAL
Trial Details
Start: 2019-06-20Est. Completion: 2027-06
Enrollment target: 356 participants Locations- infectious Disease Institute Kampala,Uganda, Kampala, Uganda
Other microbiome trials you might be interested in
Cryptococcal InfectionCryptococcal PneumoniaPulmonary CryptococcosisCryptococcal MeningitisCryptococcosis
The protocol will be carried out in accordance with International Council for Harmonisation of Technical Requirements fo…
Bethesda, United States
Cryptococcal AntigenemiaHIV-1-infectionCryptococcal InfectionCryptococcal Meningitis
This randomized clinical trial will evaluate the optimal duration of fluconazole therapy and timing of antiretroviral th…
Kampala, UgandaEst. completion Aug 30, 2031
Idiopathic CD4+ LymphocytopeniaCryptococcal MeningitisWarts
Background:
* Idiopathic CD4+ lymphocytopenia (ICL) is a condition in which there is a decreased level of CD4+ lymphocy…
Bethesda, United States